Skip to main content

JX Luxventure Group Inc.

corporate_fare Company Profile

JX Luxventure Group Inc.

JXG·NASDAQ·Trade & Services·CIK 0001546383

JX Luxventure Group Inc. is a holding company incorporated in the Marshall Islands that conducts substantially all of its business operations in China. The company focuses its business operations on the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. JX Luxventure Group Inc. operates in three segments: 1) Airline tickets and tourism services, 2) Software Solution for Tourism Cross-border operation, and 3) Tourism Cross-border Merchandise. The company's technology solutions facilitate tourism cross-border commerce and offer services in tourism and airline tickets. In 2024, the company expanded its business operations in the cross-border merchandise segment. During 2025, it continues to focus on the wholesale trade sector, specializing in duty-free and cross-border consumer goods. JX Luxventure Group Inc. also provides integrated solutions in wholesale trade, including logistics, supply chain management, and technology solutions to support the efficient distribution of tourism-related products.

JX Luxventure Group Inc. (NASDAQ:JXG) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 15 items for JXG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-22, rated 9/10. Across its 15 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for JXG spans 6-K, 20-F, SCHEDULE 13D, 4.

Recent high-impact activity:

  • JX Luxventure Closes Dazzly Investment Acquisition, Issues 2.78M Shares
  • JX Luxventure Reports 66% Revenue Growth, $11M Net Loss, and Massive Dilution Amidst Internal Control Weakness and Delisting Risk
  • JX Luxventure Group Sees Revenue Surge 66% to $83M in Fiscal 2025
  • JX Luxventure to Issue 2.78M Shares for 10% Stake in Pharmaceutical Distributor, Causing Significant Dilution
  • CEO Converts $6.27M Debt to Equity, Issuing 2.1M Shares and Causing Significant Dilution

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$82.94M
Net Income
-$11M
Diluted EPS
-$17.71
Op. Cash Flow
-$4.09M
Gross Profit
$10.43M
Operating Income
-$10.9M
Cash & Equivalents
$700.73K
Debt / Equity
0.00×
Net Margin
-13.3%
Source: 20-F · filed 2026-05-15 · accession 0001213900-26-057231

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,597 shares in JXG as of the September 15, 2026 settlement, a 83.5% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 18.0% of JXG volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,597 shares as of September 15, 2026
Change vs prior period▼ 83.5%
Days to cover1.00 at avg daily volume of 22,250
Daily short volume (FINRA facilities)18.0% of 372 shares on October 2, 2026
5-day average short volume49.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for JXG, detected from its recent SEC filings · based on capital-structure filings through 2026-04-10.

Debt-for-Equity Conversion Finalized · Significant Share Dilution

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

JXG files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with J →
$7.7
52-week range · as of 2026-05-22 $3.01 – $41.7
Market cap
$92.86M
Volume
25.9K (0.5× avg)
3-mo avg 53.1K
Live data · 2026-10-04 10:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed JXG - Latest Insights

JXG
May 22, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $7.23
Real-time Price: $7.70 info
Change: +$0.470 (+7%) info
Market Cap: $92.861M info
JXG
May 15, 2026, 9:30 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $5.27
Real-time Price: $7.70 info
Change: +$2.43 (+46%) info
Market Cap: $92.861M info
JXG
May 15, 2026, 9:30 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $7.70 info
Change: +$2.43 (+46%) info
Market Cap: $92.861M info
JXG
Apr 14, 2026, 8:38 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.95
Real-time Price: $7.70 info
Change: +$3.75 (+95%) info
Market Cap: $92.861M info
JXG
Apr 10, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.95
Real-time Price: $7.70 info
Change: +$3.75 (+95%) info
Market Cap: $92.861M info
JXG
Mar 27, 2026, 12:04 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $3.89
Real-time Price: $7.70 info
Change: +$3.82 (+98%) info
Market Cap: $92.861M info
JXG
Mar 26, 2026, 12:53 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $7.70 info
Change: +$3.92 (+104%) info
Market Cap: $92.861M info
JXG
Mar 26, 2026, 10:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.73
Real-time Price: $7.70 info
Change: +$3.97 (+106%) info
Market Cap: $92.861M info
JXG
Mar 25, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.73
Real-time Price: $7.70 info
Change: +$3.97 (+106%) info
Market Cap: $92.861M info
JXG
Mar 09, 2026, 5:47 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.07
Real-time Price: $7.70 info
Change: +$3.63 (+89%) info
Market Cap: $92.861M info
JXG
Jan 21, 2026, 5:05 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $4.36
Real-time Price: $7.70 info
Change: +$3.34 (+77%) info
Market Cap: $92.861M info
JXG
Jan 21, 2026, 5:04 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $4.36
Real-time Price: $7.70 info
Change: +$3.34 (+77%) info
Market Cap: $92.861M info
JXG
Jan 06, 2026, 5:13 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $5.59
Real-time Price: $7.70 info
Change: +$2.11 (+38%) info
Market Cap: $92.861M info
JXG
Jan 06, 2026, 9:36 AM EST
Filing Type: 6-K
Importance Score:
10
Price at Filing: $5.90
Real-time Price: $7.70 info
Change: +$1.80 (+31%) info
Market Cap: $92.861M info
JXG
Jan 05, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.90
Real-time Price: $7.70 info
Change: +$1.80 (+31%) info
Market Cap: $92.861M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets